Literature DB >> 7959092

The value of biopsies in the evaluation of chronic progressive conjunctival cicatrisation.

W Bernauer1, M J Elder, J N Leonard, P Wright, J K Dart.   

Abstract

BACKGROUND: Chronic progressive conjunctival cicatrisation is poorly understood, and therapy of this condition remains difficult. This study assessed the value of immunohistochemical investigations in the evaluation of patients who present with chronic cicatrising conjunctivitis similar to cicatricial pemphigoid (CP).
METHODS: Bulbar conjunctival biopsies from 36 patients with acute (n = 5), subacute (n = 13) and chronic (n = 18) ocular disease were studied. The biopsy was retaken in 7 patients to evaluate the present immunological findings in comparison with a biopsy more then 5 years ago. All the specimens were investigated for the presence of immunoglobulins and complement at the epithelial basement membrane, and the phenotype of the inflammatory cellular infiltrate was analysed. Twenty-nine patients were evaluated for the presence of circulating IgG-anti-basement membrane zone antibodies.
RESULTS: CP was confirmed by immunoglobulins and/or complement deposition at the epithelial basement membrane in 11 patients (31%). IgA was found to be the most frequent deposit. Eleven CP patients, mainly those with active or "burnt-out" disease, showed absence of immunoglobulins and/or complement at the conjunctival basement membrane. In 14 of 36 patients, conjunctival cicatrisation was subsequently felt to be caused by conditions other than CP. The cellular phenotype in the subepithelial conjunctiva was unspecific, but in CP the disease activity was reflected by the number of neutrophils and macrophages. Circulating IgG antibodies were found in none of the patients' serum.
CONCLUSION: Immunoglobulin and/or complement deposition at the epithelial basement membrane confirms the diagnosis of mucous membrane pemphigoid. Their absence, however, does not rule it out and is a frequent feature in very active conjunctival disease or after immunosuppressive treatment. The analysis of the cellular phenotype in mucous membrane pemphigoid may be useful in the assessment of disease activity but does not help in determining the underlying disease process causing the cicatrising conjunctivitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959092     DOI: 10.1007/BF00181996

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  17 in total

1.  Cicatricial pemphigoid.

Authors:  C S Foster
Journal:  Trans Am Ophthalmol Soc       Date:  1986

2.  Enigma of ocular cicatricial pemphigoid. A comparative study of clinical and immunological findings.

Authors:  P Wright
Journal:  Trans Ophthalmol Soc U K       Date:  1979-04

3.  Drug-induced cicatricial pemphigoid affecting the conjunctiva. Light and electron microscopic features.

Authors:  Y Pouliquen; A Patey; C S Foster; L Goichot; M Savoldelli
Journal:  Ophthalmology       Date:  1986-06       Impact factor: 12.079

4.  Antibasement membrane antibody-mediated experimental conjunctivitis.

Authors:  M I Roat; S P Alstadt; A B Carpenter; N SundarRaj; R A Thoft
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-01       Impact factor: 4.799

5.  Immunofluorescent studies of ocular cicatricial pemphigoid.

Authors:  N Furey; C West; T Andrews; P D Paul; S F Bean
Journal:  Am J Ophthalmol       Date:  1975-11       Impact factor: 5.258

Review 6.  Chronic progressive conjunctival cicatrisation.

Authors:  W Bernauer; D C Broadway; P Wright
Journal:  Eye (Lond)       Date:  1993       Impact factor: 3.775

7.  Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies.

Authors:  L S Chan; K B Yancey; C Hammerberg; H K Soong; J A Regezi; K Johnson; K D Cooper
Journal:  Arch Dermatol       Date:  1993-04

8.  Hyperproliferation of conjunctival fibroblasts from patients with cicatricial pemphigoid.

Authors:  M I Roat; G Sossi; C Y Lo; R A Thoft
Journal:  Arch Ophthalmol       Date:  1989-07

9.  The conjunctiva in acute and chronic mucous membrane pemphigoid. An immunohistochemical analysis.

Authors:  W Bernauer; P Wright; J K Dart; J N Leonard; S Lightman
Journal:  Ophthalmology       Date:  1993-03       Impact factor: 12.079

10.  Ocular rosacea. A histologic and immunopathologic study.

Authors:  T Hoang-Xuan; A Rodriguez; M M Zaltas; B A Rice; C S Foster
Journal:  Ophthalmology       Date:  1990-11       Impact factor: 12.079

View more
  9 in total

1.  Incidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand.

Authors:  Samantha Bobba; Connor Devlin; Nick Di Girolamo; Denis Wakefield; Peter McCluskey; Elsie Chan; Mark Daniell; Stephanie Watson
Journal:  Eye (Lond)       Date:  2018-06-19       Impact factor: 3.775

Review 2.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

3.  The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.

Authors:  M Victoria De Rojas; John K G Dart; Valerie P J Saw
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

4.  Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom.

Authors:  C F Radford; S Rauz; G P Williams; V P J Saw; J K G Dart
Journal:  Eye (Lond)       Date:  2012-06-22       Impact factor: 3.775

5.  Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom.

Authors:  G P Williams; C Radford; P Nightingale; J K G Dart; S Rauz
Journal:  Eye (Lond)       Date:  2011-07-29       Impact factor: 3.775

6.  Conjunctival Neutrophils Predict Progressive Scarring in Ocular Mucous Membrane Pemphigoid.

Authors:  Geraint P Williams; Peter Nightingale; Sue Southworth; Alastair K O Denniston; Paul J Tomlins; Stephen Turner; John Hamburger; Simon J Bowman; S John Curnow; Saaeha Rauz
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-10-01       Impact factor: 4.799

Review 7.  The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid.

Authors:  Mayumi Kamaguchi; Hiroaki Iwata
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

Review 8.  [Mucous membrane pemphigoid with ocular involvement. Part I: Clinical manifestations, pathogenesis and diagnosis].

Authors:  E Schmidt; T Meyer-Ter-Vehn; D Zillikens; G Geerling
Journal:  Ophthalmologe       Date:  2008-03       Impact factor: 1.174

9.  European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.

Authors:  E Schmidt; H Rashid; A V Marzano; A Lamberts; G Di Zenzo; G F H Diercks; S Alberti-Violetti; R J Barry; L Borradori; M Caproni; B Carey; M Carrozzo; G Cianchini; A Corrà; F G Dikkers; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; S Rauz; B D van Rhijn; M Roth; J Setterfield; D Zillikens; G Zambruno; B Horváth; F Caux
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-26       Impact factor: 6.166

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.